Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D01ULX
|
|||
Former ID |
DIB012602
|
|||
Drug Name |
CC-0651
|
|||
Synonyms |
Cdc34 inhibitors (cancer); Cdc34 inhibitors (cancer), Celgene
Click to Show/Hide
|
|||
Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Investigative | [1] | |
Company |
Celgene Corp
|
|||
Structure |
Download2D MOL |
|||
Formula |
C20H21Cl2NO6
|
|||
Canonical SMILES |
COCC(=O)NC(CC1=CC=C(C=C1)C2=CC(=CC(=C2)Cl)Cl)C(C(C(=O)O)O)O
|
|||
InChI |
1S/C20H21Cl2NO6/c1-29-10-17(24)23-16(18(25)19(26)20(27)28)6-11-2-4-12(5-3-11)13-7-14(21)9-15(22)8-13/h2-5,7-9,16,18-19,25-26H,6,10H2,1H3,(H,23,24)(H,27,28)/t16-,18-,19+/m0/s1
|
|||
InChIKey |
NTCBTNCWNRCBGX-YTQUADARSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.